vs
Side-by-side financial comparison of ALLIANCE ENTERTAINMENT HOLDING CORP (AENT) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
ALLIANCE ENTERTAINMENT HOLDING CORP is the larger business by last-quarter revenue ($368.7M vs $196.0M, roughly 1.9× Axsome Therapeutics, Inc.). ALLIANCE ENTERTAINMENT HOLDING CORP runs the higher net margin — 2.5% vs -14.6%, a 17.1% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -6.3%). ALLIANCE ENTERTAINMENT HOLDING CORP produced more free cash flow last quarter ($-16.9M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 32.1%).
Alliance Atlantis Communications Inc. was a media company that operated primarily as a specialty service provider in Canada. Primarily based in Toronto, Alliance Atlantis also had offices in Halifax, Los Angeles, London, Dublin, Madrid, Barcelona, Shannon, and Sydney.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
AENT vs AXSM — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $368.7M | $196.0M |
| Net Profit | $9.4M | $-28.6M |
| Gross Margin | — | — |
| Operating Margin | 4.7% | -13.8% |
| Net Margin | 2.5% | -14.6% |
| Revenue YoY | -6.3% | 65.0% |
| Net Profit YoY | 32.8% | 61.9% |
| EPS (diluted) | $0.18 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $368.7M | $196.0M | ||
| Q3 25 | $254.0M | $171.0M | ||
| Q2 25 | $227.8M | $150.0M | ||
| Q1 25 | $213.0M | $121.5M | ||
| Q4 24 | $393.7M | $118.8M | ||
| Q3 24 | $229.0M | $104.8M | ||
| Q2 24 | $236.9M | $87.2M | ||
| Q1 24 | $211.2M | $75.0M |
| Q4 25 | $9.4M | $-28.6M | ||
| Q3 25 | $4.9M | $-47.2M | ||
| Q2 25 | $5.8M | $-48.0M | ||
| Q1 25 | $1.9M | $-59.4M | ||
| Q4 24 | $7.1M | $-74.9M | ||
| Q3 24 | $397.0K | $-64.6M | ||
| Q2 24 | $2.5M | $-79.3M | ||
| Q1 24 | $-3.4M | $-68.4M |
| Q4 25 | 4.7% | -13.8% | ||
| Q3 25 | 4.2% | -27.0% | ||
| Q2 25 | 4.3% | -24.5% | ||
| Q1 25 | 1.7% | -46.9% | ||
| Q4 24 | 3.8% | -61.1% | ||
| Q3 24 | 0.9% | -59.8% | ||
| Q2 24 | 0.2% | -89.5% | ||
| Q1 24 | -0.3% | -89.7% |
| Q4 25 | 2.5% | -14.6% | ||
| Q3 25 | 1.9% | -27.6% | ||
| Q2 25 | 2.5% | -32.0% | ||
| Q1 25 | 0.9% | -48.9% | ||
| Q4 24 | 1.8% | -63.1% | ||
| Q3 24 | 0.2% | -61.7% | ||
| Q2 24 | 1.1% | -91.0% | ||
| Q1 24 | -1.6% | -91.1% |
| Q4 25 | $0.18 | $-0.55 | ||
| Q3 25 | $0.10 | $-0.94 | ||
| Q2 25 | $0.11 | $-0.97 | ||
| Q1 25 | $0.04 | $-1.22 | ||
| Q4 24 | $0.14 | $-1.54 | ||
| Q3 24 | $0.01 | $-1.34 | ||
| Q2 24 | $0.05 | $-1.67 | ||
| Q1 24 | $-0.07 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $322.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $117.6M | $88.3M |
| Total Assets | $434.1M | $689.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $322.9M | ||
| Q3 25 | — | $325.3M | ||
| Q2 25 | — | $303.0M | ||
| Q1 25 | — | $300.9M | ||
| Q4 24 | — | $315.4M | ||
| Q3 24 | $4.3M | $327.3M | ||
| Q2 24 | $1.1M | $315.7M | ||
| Q1 24 | $1.6M | $331.4M |
| Q4 25 | $117.6M | $88.3M | ||
| Q3 25 | $108.1M | $73.7M | ||
| Q2 25 | $103.2M | $73.1M | ||
| Q1 25 | $97.4M | $53.2M | ||
| Q4 24 | $95.6M | $57.0M | ||
| Q3 24 | $88.0M | $92.9M | ||
| Q2 24 | $87.6M | $102.9M | ||
| Q1 24 | $85.1M | $144.0M |
| Q4 25 | $434.1M | $689.8M | ||
| Q3 25 | $383.0M | $669.3M | ||
| Q2 25 | $361.2M | $639.8M | ||
| Q1 25 | $349.4M | $596.7M | ||
| Q4 24 | $401.7M | $568.5M | ||
| Q3 24 | $395.7M | $561.5M | ||
| Q2 24 | $340.8M | $548.2M | ||
| Q1 24 | $324.0M | $545.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.5M | $-18.7M |
| Free Cash FlowOCF − Capex | $-16.9M | $-18.7M |
| FCF MarginFCF / Revenue | -4.6% | -9.6% |
| Capex IntensityCapex / Revenue | 0.1% | 0.0% |
| Cash ConversionOCF / Net Profit | -1.76× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.4M | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.5M | $-18.7M | ||
| Q3 25 | $2.7M | $1.0M | ||
| Q2 25 | $10.7M | $-32.4M | ||
| Q1 25 | $2.5M | $-43.4M | ||
| Q4 24 | $25.3M | $-26.2M | ||
| Q3 24 | $-11.6M | $-18.6M | ||
| Q2 24 | $9.7M | $-30.1M | ||
| Q1 24 | $20.0M | $-53.5M |
| Q4 25 | $-16.9M | $-18.7M | ||
| Q3 25 | $2.4M | $988.0K | ||
| Q2 25 | $10.7M | $-32.4M | ||
| Q1 25 | $2.4M | $-43.7M | ||
| Q4 24 | — | $-26.2M | ||
| Q3 24 | $-11.6M | $-18.7M | ||
| Q2 24 | — | $-30.2M | ||
| Q1 24 | $20.0M | $-53.6M |
| Q4 25 | -4.6% | -9.6% | ||
| Q3 25 | 0.9% | 0.6% | ||
| Q2 25 | 4.7% | -21.6% | ||
| Q1 25 | 1.1% | -36.0% | ||
| Q4 24 | — | -22.1% | ||
| Q3 24 | -5.1% | -17.9% | ||
| Q2 24 | — | -34.6% | ||
| Q1 24 | 9.4% | -71.4% |
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 0.0% | 0.1% |
| Q4 25 | -1.76× | — | ||
| Q3 25 | 0.56× | — | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | -29.31× | — | ||
| Q2 24 | 3.85× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
